[Article] The new era of the SOFA score: Data-driven innovations for intensive care medicine
The Sequential Organ Failure Assessment (SOFA) score is a clinical tool developed in the 1990s to assess the extent of organ dysfunction in critically ill patients, especially those admitted to intensive care units (ICUs). The score was initially introduced to standardize the assessment of organ failure across different ICUs, allowing for better comparisons and improving patient management.
The SOFA is based on six organ systems: respiratory, cardiovascular, hepatic, coagulation, renal, and neurological, to which points are assigned according to the severity of the dysfunction. Physicians assign a total score ranging from 0 to 24, with higher values indicating greater severity. For example, a score of 2 or higher in any system suggests a significant level of organ dysfunction or failure.
Healthcare professionals use the SOFA score to monitor disease progression and estimate clinical outcomes, such as mortality risk. It is commonly used in cases of sepsis, trauma, and other conditions that can progress to multiple organ failure.
The widespread acceptance of the SOFA stems from its simplicity and effectiveness. It is widely used in clinical practice and research to quantify the severity of organ dysfunction and evaluate the efficacy of therapeutic interventions. However, since its creation, knowledge about serious illnesses, organ failure, and patient outcomes has evolved significantly. Consequently, there is growing interest in updating the score to reflect the most recent scientific and technological advances.
In 2023, an international group of over 80 experts in intensive care medicine, statistics, epidemiology, and organ dysfunctions began work on revising the score. The new model, called SOFA 2, has just been published as a result of this multidisciplinary and data-driven effort, based on the analysis of over 3.4 million ICU admissions from 10 countries.
Brazil has played a prominent role in this project. The methods group is led by Professor Otavio Ranzani and includes Professor Marcio Soares. Professor Jorge Salluh coordinates the data validation group, and Professors Ary Serpa Neto, Fernando Zampieri, Ederlon Rezende, and Suzana Lobo are also part of the team of experts. Contemporary data from the Epimed Monitor system, compiled in the ORCHESTRA trial database, represent one of the main sources used in the development of the new score.
To read the complete material, download the file.
